Clinical Trials Browser

Phase 2 × Adenomatous Polyps × Erlotinib Hydrochloride × Clear all

NCT00754494 2015-01-06

Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma

Phase 2 Completed

45 enrolled 18 charts

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Adenomatous Polyps